Dougherty & Co Starts Bio-Reference Laboratories (BRLI) at Buy; Expect Continued Investment In Innovation To Yield Solid Growth
Tweet Send to a Friend
Dougherty & Co initiates coverage on Bio-Reference Laboratories (NASDAQ: BRLI) with a Buy. PT $31.
Dougherty analyst says, "BRLI has ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Dougherty analyst says, "BRLI has ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
